Tianagliflozin is a sodium/glucose cotransporter 2 (SGLT-2) inhibitor with potential for investigation in type 2 diabetes.
References:
[1]. ZHANG Ling-Yu, et al. Synthesis and Crystal Structure of Tianagliflozin Triacetate[J]. JIEGOU HUAXUE, 2013, 33(1): 85-89.
















